MS21.06 Immunotherapy - Sequence or Combination?

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.177
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Combination Immunotherapy for Melanoma

JAMA Oncology
Cancer ResearchOncology
2015English

Tumor Burden Affects Efficacy of Combination Immunotherapy

Cancer Discovery
Oncology
2019English

Combination Strategies of Checkpoint Immunotherapy in Metastatic Breast Cancer

OncoTargets and Therapy
OncologyPharmacology
2020English

The Future of Cancer Treatment: Immunomodulation, CARs and Combination Immunotherapy

Nature Reviews Clinical Oncology
Oncology
2016English

OS7 - 145 Combination Immunotherapy for Glioma: Beyond PD 1 Inhibition

Canadian Journal of Neurological Sciences
MedicineNeurology
2016English

OX40 Agonists and Combination Immunotherapy: Putting the Pedal to the Metal

Frontiers in Oncology
Cancer ResearchOncology
2015English

Feverish Quest for Ebola Immunotherapy: Straight or Cocktail?

Trends in Microbiology
VirologyInfectious DiseasesMicrobiology
2016English

Hyperprogression and Immunotherapy: Fact, Fiction, or Alternative Fact?

Trends in Cancer
Cancer ResearchOncology
2020English

Tumor Neoantigen Heterogeneity Thresholds Provide a Time Window for Combination Immunotherapy

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy